Recent Achievements in Nano-based Technologies for Ocular Disease Diagnosis and Treatment, Review and Update

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2022 Aug 2

PMID 35918688

Authors

Mehrdad Afarid

Shirin Mahmoodi

Roghayyeh Baghban

Affiliations

Soon will be listed here.

Abstract

Ocular drug delivery is one of the most challenging endeavors among the various available drug delivery systems. Despite having suitable drugs for the treatment of ophthalmic disease, we have not yet succeeded in achieving a proper drug delivery approach with the least adverse effects. Nanotechnology offers great opportunities to overwhelm the restrictions of common ocular delivery systems, including low therapeutic effects and adverse effects because of invasive surgery or systemic exposure. The present review is dedicated to highlighting and updating the recent achievements of nano-based technologies for ocular disease diagnosis and treatment. While further effort remains, the progress illustrated here might pave the way to new and very useful ocular nanomedicines.

Citing Articles

Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.

Kaur G, Bisen S, Singh N Biophys Rev (Melville). 2024; 5(4):041305.

PMID: 39512331 PMC: 11540445. DOI: 10.1063/5.0214899.

Nanomedicine in glaucoma treatment; Current challenges and future perspectives.

Iqbal H, Razzaq A, Zhou D, Lou J, Xiao R, Lin F Mater Today Bio. 2024; 28:101229.

PMID: 39296355 PMC: 11409099. DOI: 10.1016/j.mtbio.2024.101229.

Harnessing Nanoparticles to Overcome Antimicrobial Resistance: Promises and Challenges.

Mishra A, Jyoti A, Aayush K, Saxena J, Sharma K Curr Pharm Des. 2024; 31(4):292-306.

PMID: 39219123 DOI: 10.2174/0113816128326718240809091654.

Application of Silicone in Ophthalmology: A Review.

Mladenovic T, Zivic F, Petrovic N, Njezic S, Pavic J, Kotorcevic N Materials (Basel). 2024; 17(14).

PMID: 39063747 PMC: 11278226. DOI: 10.3390/ma17143454.

In vivo and in vitro efficacy of the ithmid kohl/zinc-oxide nanoparticles, ithmid kohl/Aloe vera, and zinc-oxide nanoparticles/Aloe vera for the treatment of bacterial endophthalmitis.

Obaid Hasson S, Hasan H, Abdul Kadhem Salman S, Judi H, Akrami S, Saki M Sci Rep. 2024; 14(1):15746.

PMID: 38977762 PMC: 11231241. DOI: 10.1038/s41598-024-66341-1.

References

Honda M, Asai T, Oku N, Araki Y, Tanaka M, Ebihara N . Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomedicine. 2013; 8:495-503. PMC: 3576887. DOI: 10.2147/IJN.S30725. View

Salmani Javan E, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N . Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation. Asian Pac J Cancer Prev. 2022; 23(2):519-527. PMC: 9272620. DOI: 10.31557/APJCP.2022.23.2.519. View

Yang J, Gong X, Fang L, Fan Q, Cai L, Qiu X . Potential of CeCl@mSiO nanoparticles in alleviating diabetic cataract development and progression. Nanomedicine. 2017; 13(3):1147-1155. DOI: 10.1016/j.nano.2016.12.021. View

Tummala G, Joffre T, Lopes V, Liszka A, Buznyk O, Ferraz N . Hyperelastic Nanocellulose-Reinforced Hydrogel of High Water Content for Ophthalmic Applications. ACS Biomater Sci Eng. 2021; 2(11):2072-2079. DOI: 10.1021/acsbiomaterials.6b00484. View

Servais A, Kienzle A, Valenzuela C, Ysasi A, Wagner W, Tsuda A . Structural Heteropolysaccharide Adhesion to the Glycocalyx of Visceral Mesothelium. Tissue Eng Part A. 2017; 24(3-4):199-206. PMC: 5792244. DOI: 10.1089/ten.TEA.2017.0042. View

Palla S, Biswas J, Nagesha C . Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis. Indian J Ophthalmol. 2015; 63(10):767-70. PMC: 4728974. DOI: 10.4103/0301-4738.171505. View

Hajizadeh M, Maleki H, Barani M, Fahmidehkar M, Mahmoodi M, Torkzadeh-Mahani M . cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci. 2019; 14(5):448-458. PMC: 6827193. DOI: 10.4103/1735-5362.268206. View

Barani M, Nematollahi M, Zaboli M, Mirzaei M, Torkzadeh-Mahani M, Pardakhty A . In silico and in vitro study of magnetic niosomes for gene delivery: The effect of ergosterol and cholesterol. Mater Sci Eng C Mater Biol Appl. 2018; 94:234-246. DOI: 10.1016/j.msec.2018.09.026. View

Chong D, Johnson M, Huynh T, Hall E, Comer G, Fish D . Vitreous penetration of orally administered famciclovir. Am J Ophthalmol. 2009; 148(1):38-42.e1. DOI: 10.1016/j.ajo.2009.02.010. View

10.

Zhang J, Jiao J, Niu M, Gao X, Zhang G, Yu H . Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective. Int J Nanomedicine. 2021; 16:6497-6530. PMC: 8473849. DOI: 10.2147/IJN.S329831. View

11.

Malhotra N, Lee J, Liman R, Ruallo J, Villaflores O, Ger T . Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review. Molecules. 2020; 25(14). PMC: 7397295. DOI: 10.3390/molecules25143159. View

12.

Buosi F, Alaimo A, Di Santo M, Elias F, Linares G, Acebedo S . Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: Impact on human ARPE-19 culture cells. Int J Biol Macromol. 2020; 165(Pt A):804-821. DOI: 10.1016/j.ijbiomac.2020.09.234. View

13.

Shen H, Chan E, Lee J, Bee Y, Lin T, Dusting G . Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery. Nanomedicine (Lond). 2015; 10(13):2093-107. DOI: 10.2217/nnm.15.47. View

14.

Ghate D, Brooks W, McCarey B, Edelhauser H . Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci. 2007; 48(5):2230-7. DOI: 10.1167/iovs.06-0954. View

15.

Smith S, Lorenz D, Peace J, McLeod K, Crockett R, Vogel R . Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery. Clin Ophthalmol. 2010; 4:983-91. PMC: 2938279. DOI: 10.2147/opth.s10696. View

16.

Nguyen V, Qian W, Li Y, Liu B, Aaberg M, Henry J . Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging. Nat Commun. 2021; 12(1):34. PMC: 7782787. DOI: 10.1038/s41467-020-20276-z. View

17.

Liu D, Lian Y, Fang Q, Liu L, Zhang J, Li J . Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Int J Biol Macromol. 2018; 116:1026-1036. DOI: 10.1016/j.ijbiomac.2018.05.113. View

18.

Ma P, Mumper R . Paclitaxel Nano-Delivery Systems: A Comprehensive Review. J Nanomed Nanotechnol. 2013; 4(2):1000164. PMC: 3806207. DOI: 10.4172/2157-7439.1000164. View

19.

Liu B, Kang C, Fang F . Biometric Measurement of Anterior Segment: A Review. Sensors (Basel). 2020; 20(15). PMC: 7435894. DOI: 10.3390/s20154285. View

20.

Agrahari V, Agrahari V, Mandal A, Pal D, Mitra A . How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches. Expert Opin Drug Deliv. 2016; 14(10):1145-1162. DOI: 10.1080/17425247.2017.1272569. View